PIPELINE

Engineering the medicines of tomorrow

Engineering the medicines of tomorrow

We are dedicated to developing breakthrough medicines to help address the unmet medical needs of patients.

Based on our advanced antibody technology platforms, we have built a comprehensive portfolio of potential drug candidates and are developing novel therapies for people with cancer and autoimmune diseases.

An overview of the complete portfolio of MorphoSys clinical trials and the most advanced clinical programs developed by our partners can be found at morphosys.com/pipeline